CDK-话题@MedSci

#CDK#

85篇内容 | 2942人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1435507, encodeId=8bc6143550e86, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=CSCO2018大家访谈录│王晓稼教授：内分泌+CDK4/6抑制剂还是化疗, objectType=article, longId=149675, objectId=8caf1496e50f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8caf1496e50f, replyNumber=0, likeNumber=77, createdTime=2018-09-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8caf1496e50f, moduleTitle=CSCO2018大家访谈录│王晓稼教授：内分泌+CDK4/6抑制剂还是化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8caf1496e50f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435506, encodeId=42311435506bd, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=World J Gastroentero：胃癌患者中CDK5RAP3和DDRGK1低表达预测了胃癌患者预后不良, objectType=article, longId=149055, objectId=8a1f149055a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a1f149055a6, replyNumber=0, likeNumber=65, createdTime=2018-09-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a1f149055a6, moduleTitle=World J Gastroentero：胃癌患者中CDK5RAP3和DDRGK1低表达预测了胃癌患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a1f149055a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435505, encodeId=1c9d1435505f9, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=胡夕春教授：乳腺癌治疗新突破，CDK4/6抑制剂独领风骚！, objectType=article, longId=140525, objectId=33f81405254d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33f81405254d, replyNumber=0, likeNumber=69, createdTime=2018-06-13, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33f81405254d, moduleTitle=胡夕春教授：乳腺癌治疗新突破，CDK4/6抑制剂独领风骚！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33f81405254d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435504, encodeId=037214355047a, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Blood：CDK2泛素依赖性降解，可通过靶向PRDX2诱导AML细胞分化, objectType=article, longId=137587, objectId=c0c713e58775, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0c713e58775, replyNumber=0, likeNumber=94, createdTime=2018-05-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0c713e58775, moduleTitle=Blood：CDK2泛素依赖性降解，可通过靶向PRDX2诱导AML细胞分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0c713e58775)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435503, encodeId=ed6f143550376, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Blood：基因组CDKN2A/2B缺失，使费城染色体阳性的ALL患者预后更差，即使采用aSCT治疗。, objectType=article, longId=127360, objectId=5f7e12e36045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7e12e36045, replyNumber=0, likeNumber=42, createdTime=2018-01-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7e12e36045, moduleTitle=Blood：基因组CDKN2A/2B缺失，使费城染色体阳性的ALL患者预后更差，即使采用aSCT治疗。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7e12e36045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435502, encodeId=2496143550248, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=CLIN CANCER RES：肢端黑色素瘤CDK4通路基因改变表明CDK4/6抑制可以作为靶向疗法, objectType=article, longId=121178, objectId=6c591211e82d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c591211e82d, replyNumber=0, likeNumber=0, createdTime=2017-11-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c591211e82d, moduleTitle=CLIN CANCER RES：肢端黑色素瘤CDK4通路基因改变表明CDK4/6抑制可以作为靶向疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c591211e82d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435501, encodeId=a6ca143550182, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Nature：CDK4/6抑制剂--ER+乳腺癌治疗新选择!, objectType=article, longId=118337, objectId=fa9711833ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa9711833ec4, replyNumber=0, likeNumber=72, createdTime=2017-11-02, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa9711833ec4, moduleTitle=Nature：CDK4/6抑制剂--ER+乳腺癌治疗新选择!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa9711833ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435500, encodeId=9b66143550070, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=[SIBCS2017]在故事开始的地方，Richard S. Finn教授谈CDK4/6抑制剂成功的漫漫长路, objectType=article, longId=117554, objectId=372411e55468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=372411e55468, replyNumber=0, likeNumber=66, createdTime=2017-10-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=372411e55468, moduleTitle=[SIBCS2017]在故事开始的地方，Richard S. Finn教授谈CDK4/6抑制剂成功的漫漫长路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=372411e55468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435499, encodeId=1ce8143549912, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Transl Onc：CDKs抑制剂——结合常规抗癌药可以使癌细胞迅速迈向死亡！, objectType=article, longId=111238, objectId=c2d611123838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2d611123838, replyNumber=0, likeNumber=100, createdTime=2017-08-31, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2d611123838, moduleTitle=Transl Onc：CDKs抑制剂——结合常规抗癌药可以使癌细胞迅速迈向死亡！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2d611123838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435498, encodeId=b9df1435498be, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Nature：惊人发现！“重磅抗癌药”CDK4/6抑制剂竟然也是免疫疗法, objectType=article, longId=110335, objectId=e6bf1103359b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6bf1103359b, replyNumber=0, likeNumber=98, createdTime=2017-08-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6bf1103359b, moduleTitle=Nature：惊人发现！“重磅抗癌药”CDK4/6抑制剂竟然也是免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6bf1103359b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435497, encodeId=945d143549e01, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Oncologist:乳腺癌CDK4/6抑制剂治疗的潜在副作用都有啥？, objectType=article, longId=106365, objectId=2cb21063650c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cb21063650c, replyNumber=0, likeNumber=77, createdTime=2017-07-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cb21063650c, moduleTitle=Oncologist:乳腺癌CDK4/6抑制剂治疗的潜在副作用都有啥？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cb21063650c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435496, encodeId=6557143549673, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=CANCER RES：三阴性乳腺癌高表达CDK7与不良预后有关，可作为治疗靶点, objectType=article, longId=106363, objectId=36b310636345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36b310636345, replyNumber=0, likeNumber=0, createdTime=2017-07-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36b310636345, moduleTitle=CANCER RES：三阴性乳腺癌高表达CDK7与不良预后有关，可作为治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36b310636345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435495, encodeId=b7c41435495af, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Blood：CDK9是成人T细胞白血病/淋巴瘤的一种新的特异性分子靶点, objectType=article, longId=104072, objectId=6be91040e238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6be91040e238, replyNumber=0, likeNumber=117, createdTime=2017-07-01, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6be91040e238, moduleTitle=Blood：CDK9是成人T细胞白血病/淋巴瘤的一种新的特异性分子靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6be91040e238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435494, encodeId=cbfd1435494fe, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Nature：这一指标可预测CDK4/6抑制剂抗癌效果, objectType=article, longId=101718, objectId=b103101e18e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b103101e18e7, replyNumber=0, likeNumber=92, createdTime=2017-06-15, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b103101e18e7, moduleTitle=Nature：这一指标可预测CDK4/6抑制剂抗癌效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b103101e18e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435493, encodeId=b444143549304, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=SCI REP：启动子高甲基化使散发性甲状旁腺腺瘤中的CDKN2A，CDKN2B和RASSF1A基因失活, objectType=article, longId=101494, objectId=24d610149418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24d610149418, replyNumber=0, likeNumber=70, createdTime=2017-06-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24d610149418, moduleTitle=SCI REP：启动子高甲基化使散发性甲状旁腺腺瘤中的CDKN2A，CDKN2B和RASSF1A基因失活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24d610149418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435492, encodeId=2bf2143549273, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=The Oncologist：Palbociclib治疗CDKN2A突变难治性子宫平滑肌肉瘤的疗效良好, objectType=article, longId=92657, objectId=e1da9265eb5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1da9265eb5, replyNumber=0, likeNumber=62, createdTime=2017-03-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1da9265eb5, moduleTitle=The Oncologist：Palbociclib治疗CDKN2A突变难治性子宫平滑肌肉瘤的疗效良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1da9265eb5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435491, encodeId=981e143549133, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Science：忘记PD-L1吧，破坏Cdk5也能促进抗肿瘤免疫反应, objectType=article, longId=73598, objectId=b0cde3598a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0cde3598a5, replyNumber=0, likeNumber=64, createdTime=2016-07-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0cde3598a5, moduleTitle=Science：忘记PD-L1吧，破坏Cdk5也能促进抗肿瘤免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0cde3598a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435490, encodeId=b68714354907f, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=ASCO 2016：CDK4/CDK6抑制剂Abemaciclib转移性乳腺癌II期临床试验积极结果（MONARCH 1试验）, objectType=article, longId=70373, objectId=0c80e0373e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c80e0373e2, replyNumber=0, likeNumber=37, createdTime=2016-06-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c80e0373e2, moduleTitle=ASCO 2016：CDK4/CDK6抑制剂Abemaciclib转移性乳腺癌II期临床试验积极结果（MONARCH 1试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c80e0373e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435489, encodeId=4fe21435489d8, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=Cell：CDK7可能成为三阴性乳腺癌划时代性靶点, objectType=article, longId=56621, objectId=2461566210b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2461566210b, replyNumber=0, likeNumber=69, createdTime=2015-09-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2461566210b, moduleTitle=Cell：CDK7可能成为三阴性乳腺癌划时代性靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2461566210b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435488, encodeId=e3fe143548857, content=<a href='/topic/show?id=09dc439915' target=_blank style='color:#2F92EE;'>#CDK#</a>, objectTitle=J Neurosci：阻断关键酶Cdk5减少中风损伤, objectType=article, longId=37170, objectId=d4c53e170a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4c53e170a9, replyNumber=0, likeNumber=90, createdTime=2014-07-02, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4c53e170a9, moduleTitle=J Neurosci：阻断关键酶Cdk5减少中风损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4c53e170a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CDK

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

CSCO2018大家访谈录│王晓稼教授：内分泌+CDK4/6抑制剂还是化疗

2018-09-28

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

World J Gastroentero：胃癌患者中CDK5RAP3和DDRGK1低表达预测了胃癌患者预后不良

2018-09-19

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

胡夕春教授：乳腺癌治疗新突破，CDK4/6抑制剂独领风骚！

2018-06-13

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Blood：CDK2泛素依赖性降解，可通过靶向PRDX2诱导AML细胞分化

2018-05-10

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Blood：基因组CDKN2A/2B缺失，使费城染色体阳性的ALL患者预后更差，即使采用aSCT治疗。

2018-01-24

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

CLIN CANCER RES：肢端黑色素瘤CDK4通路基因改变表明CDK4/6抑制可以作为靶向疗法

2017-11-25

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Nature：CDK4/6抑制剂--ER+乳腺癌治疗新选择!

2017-11-02

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

[SIBCS2017]在故事开始的地方，Richard S. Finn教授谈CDK4/6抑制剂成功的漫漫长路

2017-10-27

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Transl Onc：CDKs抑制剂——结合常规抗癌药可以使癌细胞迅速迈向死亡！

2017-08-31

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Nature：惊人发现！“重磅抗癌药”CDK4/6抑制剂竟然也是免疫疗法

2017-08-22

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Oncologist:乳腺癌CDK4/6抑制剂治疗的潜在副作用都有啥？

2017-07-24

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

CANCER RES：三阴性乳腺癌高表达CDK7与不良预后有关，可作为治疗靶点

2017-07-24

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Blood：CDK9是成人T细胞白血病/淋巴瘤的一种新的特异性分子靶点

2017-07-01

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Nature：这一指标可预测CDK4/6抑制剂抗癌效果

2017-06-15

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

SCI REP：启动子高甲基化使散发性甲状旁腺腺瘤中的CDKN2A，CDKN2B和RASSF1A基因失活

2017-06-12

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

The Oncologist：Palbociclib治疗CDKN2A突变难治性子宫平滑肌肉瘤的疗效良好

2017-03-22

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Science：忘记PD-L1吧，破坏Cdk5也能促进抗肿瘤免疫反应

2016-07-25

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

ASCO 2016：CDK4/CDK6抑制剂Abemaciclib转移性乳腺癌II期临床试验积极结果（MONARCH 1试验）

2016-06-11

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

Cell：CDK7可能成为三阴性乳腺癌划时代性靶点

2015-09-27

zhouqu_8 (审核中...)

前往app查看评论内容

#CDK#

J Neurosci：阻断关键酶Cdk5减少中风损伤

2014-07-02

科室
- - 订阅+
  - 更多科室
工具
服务